BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 16540035)

  • 1. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
    Lozano JV; Redón J; Cea-Calvo L; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J
    Rev Esp Cardiol; 2006 Feb; 59(2):136-42. PubMed ID: 16540035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
    Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J;
    J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study.
    Navarro J; Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Bonet A; González-Esteban J
    Blood Press; 2007; 16(1):20-7. PubMed ID: 17453748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population.
    Barrios V; Escobar C; Calderon A; Ribas L; Marti D; Asin E
    Blood Press; 2008; 17(2):110-5. PubMed ID: 18568700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic left ventricular hypertrophy and arterial stiffness: the Ohasama study.
    Watabe D; Hashimoto J; Hatanaka R; Hanazawa T; Ohba H; Ohkubo T; Kikuya M; Totsune K; Imai Y
    Am J Hypertens; 2006 Dec; 19(12):1199-205. PubMed ID: 17161763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of left ventricular hypertrophy in Finnish primary health care hypertensive patients.
    Kumpusalo E; Lappi J; Miettinen H; Takala J
    J Hum Hypertens; 2001 Apr; 15(4):255-8. PubMed ID: 11319673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
    Okin PM; Devereux RB; Gerdts E; Snapinn SM; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Lindholm LH; Dahlöf B;
    Circulation; 2006 Mar; 113(12):1588-96. PubMed ID: 16534012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study.
    Cea-Calvo L; Conthe P; Gómez-Fernández P; de Alvaro F; Fernández-Pérez C;
    Cardiovasc Diabetol; 2006 Nov; 5():23. PubMed ID: 17083718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
    Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
    J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prevalence of cardiovascular risk factors in a population of essential hypertension patients].
    Gavaldà L; Ramón JM; Torras MG; Martínez Amenós A; Rama H; Sarrias X
    Rev Esp Cardiol; 1993 Oct; 46(10):626-32. PubMed ID: 8234997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy.
    Smilde TD; Asselbergs FW; Hillege HL; Voors AA; Kors JA; Gansevoort RT; van Gilst WH; de Jong PE; Van Veldhuisen DJ
    Am J Hypertens; 2005 Mar; 18(3):342-7. PubMed ID: 15797651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of left ventricular hypertrophy as assessed by electrocardiogram in treated hypertensive persons in general practice.
    van den Hoogen JP; van Kruijsdijk MC; van Ree JW; Mokkink HG; Thien T; van Weel C
    J Hum Hypertens; 1993 Oct; 7(5):473-7. PubMed ID: 8263888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular hypertrophy in hypertensive type 2 diabetic patients according to renal function.
    Blanchet Deverly A; Kangambega P; Hue K; Donnet JP; Merault H; Foucan L
    Diabetes Metab; 2009 Sep; 35(4):280-6. PubMed ID: 19423378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular hypertrophy in hypertensive patients in Indian primary care: prevalence and effect of treatment with sustained release indapamide.
    Lokhandwala Y; Damle A
    Curr Med Res Opin; 2004 May; 20(5):639-44. PubMed ID: 15140328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and determinants of electrocardiographic left ventricular hypertrophy among a multiethnic population of postmenopausal women (The Women's Health Initiative).
    Oberman A; Prineas RJ; Larson JC; LaCroix A; Lasser NL
    Am J Cardiol; 2006 Feb; 97(4):512-9. PubMed ID: 16461048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension.
    Brown DW; Giles WH; Croft JB
    Am Heart J; 2000 Dec; 140(6):848-56. PubMed ID: 11099987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.